Introduction
Histidine is ubiquitous in metalloenzymes because its imidazole side chain is able to coordinate to a vast array of metal centres in various oxidation states. 1 Typically, the imidazole is coordinated 20 through one of its nitrogen atoms, either N δ or N ε . In addition, imidazole and its substituted derivatives constitute versatile precursors for the formation of N-heterocyclic carbenes (NHCs), a powerful class of spectator ligands for transition metal chemistry. 2 Hence, modification of histidine to a NHC precursor 25 provides a straightforward approach to bioorganometallic chemistry, 3 as the metal-carbene complex enables the exploitation of typical organometallic function such as catalysis, while the peptidic backbone offers opportunities for peptidic transformations and hence biochemical engineering of the 30 hybride. For example, specific structural conformations may be induced that affect the organometallic site. Peptide-based organometallic conjugates have been successfully employed, 4 for example for enzyme-controlled enantioselective catalysis. 5 While protic metal complexes of NH,NH-imidazolylidenes, 35 i.e. tautomers of imidazole, are known, 6 their synthesis often involves formation of the heterocycle within the metal coordination sphere, which precludes the use of histidine as a starting material. Alternatively, alkylation of the side-chain nitrogens of histidine constitutes a straightforward process to 40 generate NHC derivatives that will not suffer from potential tautomerisation to the imidazole isomer. 7 Such an approach has been used previously to prepare peptide-based imidazol(in)ylidene 8 and thiazolylidene 9 metal complexes. Building on pioneering work by Erker, 10 we have developed a 45 synthetic protocol to histidylidene (i.e. histidine-derived NHC) complexes as catalyst precursors for transfer hydrogenation and for the catalytic hydrosilylation of ketones. 11 The availability of appropriate stereospecific methodologies for the preparation of monopeptide organometallic complexes thus allows 50 modifications of the biochemical scaffold to be targeted. Here we report the functionalisation of the histidylidene backbone with a small oligopeptide using peptide coupling and the impact of these modifications on the (catalytic) activity of the metal centre. 12 This approach provides access to catalytically active NHC complexes 55 with a peptidic environment around the metal centre as novel models of metalloenzymes.
Results and Discussion

Synthesis of alanine-based histidylidene metal complexes
The synthesis of the alanine-containing histidinium ligand 60 precursors 4a and 4b started from the known 13 N ε -methylated histidine Boc-His(Me)-OMe 1 (Scheme 1). Cleavage of the Boc protecting group at the N-terminus was effected with methanolic HCl thus providing the dihydrochloride salt H-His(Me)-OMe·2HCl 2. Deprotection with TFA was equally successful, 14 65 however the obtained trifluoroacetate salt was significantly more hygroscopic than the chloride salt and hence less easy to handle. The C-protected methyl-histidine 2 was subsequently used for amino acid coupling reactions. These reactions were all performed using HATU as the coupling agent according to a 70 modified literature procedure. 15 Other standard and less costly agents such as DCC 16 or N-mesyl-benzotriazole 17 were also evaluated, though these methods failed to give the desired peptide bond. According to route A (Scheme 1), the free amine 2 was reacted with commercially available Boc-L-alanine to give the desired dipeptide Boc-Ala-His(Me)-OMe. The Boc protecting 5 group was then removed using a solution of HCl in 1,4-dioxane 18 and a further alanine residue was introduced to give the tripeptide Boc-Ala 2 -His(Me)-OMe 3a.
The deprotection-coupling sequence was repeated to synthesise the tetrapeptide Boc-Ala 3 -His(Me)-OMe 3b. Successful coupling was indicated by high- 10 resolution mass spectrometry and by the presence of three distinct carbonyl signals in the 13 C{ 1 H}NMR spectrum of 3a in CDCl 3 for the two amide functionalities and one ester group in the δ C 172-173 ppm range, and a carbamide resonance at δ C 155 ppm. Likewise, the tetrapeptide 3b showed three different amide and 15 one ester carbonyl resonances in the δ C 173-176 ppm range as well as a carbamide resonance at higher field (δ C 158 ppm, CD 3 OD solution).
Alternatively, the oligopeptide tether can be synthesised first (route B). Thus deprotection of the alanine dipeptide Boc-Ala 2 - 20 OMe or tripeptide Boc-Ala 3 -OMe at the C-terminus using LiOH followed by careful neutralisation and subsequent coupling to the free amine 2 yielded the oligopeptides 3a-b. Even though both routes gave the desired oligopeptides 3 in the same number of steps, route B presents the significant advantage to be convergent 25 rather than a completely linear reaction sequence. The imidazole ring was then alkylated by gently heating 3 with MeI in MeCN to give the N δ ,N ε -dimethylated histidinium oligopeptides Boc-Ala n -His*-OMe 4a (n = 2) and 4b (n = 3). The formation of the imidazolium salts was indicated by the diagnostic downfield shift 30 of the C δ H and C ε H resonances in the 1 H NMR spectrum, e.g. from δ H 6.99 to 7.39 ppm and from δ H 7.70 to 8.85 ppm, respectively, for 4b (in CD 3 OD). Both ligand precursors 4a and 4b were highly hygroscopic solids and were obtained as single enantiomers as demonstrated by the presence of one set of signals 35 in the NMR spectra. They both displayed optical activity, [α] D 20 = −43° and −37° for 4a and 4b, respectively (c = 1 in MeOH). The histidinium salts 4a-b were successfully metallated using a standard transmetallation procedure via the in situ formation of a silver carbene intermediate. As described previously, 11 ambient 40 temperature and short reaction times were crucial for the full retention of the configuration at the α-carbon of histidine. Subsequent transmetallation with [Ir(Cp*)Cl 2 ] 2 or [Rh(cod)Cl] 2 afforded the corresponding peptide-based histidylidene iridium(III) and rhodium(I) complexes 5a and 6a-b, respectively 45 (Scheme 2). Formation of the complexes was supported by the disappearance of the signal for the C ε -bound proton in the 1 H NMR spectra and by the downfield shift of the carbene signal in the 13 C NMR spectra to δ C 156.9, 182.9 and 182.3 ppm for 5a, 6a and 6b, respectively. Of note, the NMR spectra of all three 50 complexes showed the presence of two rotamers, as expected from the slow rotation about the M-C carbene bond. 11, 19 The resonances attributed to C δ H and COOCH 3 are most diagnostic and appeared as two sets of signals each. For example in 6a, two signals for C δ H were observed at δ H 6.56 and 6.60 ppm (1:0.9 55 integral ratio) and the methylester was resolved at δ H 3.67 and 3.70 ppm. The enantiopurity of the peptidic histidylidene ligand was confirmed by 31 P NMR spectroscopy after coordination of (S)-Ph-binepine 20 to the rhodium centre in 6a in the presence of KPF 6 (Scheme 2). The resulting cationic phosphine complex 7 60 displayed two doublets in a 1:0.9 integral ratio in the 31 P{ 1 H}NMR spectrum, corresponding to the rotamer ratio observed for 6a. This pattern is consistent with related enantiopure histidylidene rhodium complexes. 11b In contrast, when the silver carbene intermediate was formed using reflux 65 temperature and longer reaction times, the rhodium complex 6a displayed a more complicated 1 H NMR spectrum. Four distinct 5 signals were observed for C δ H as well as for the COOCH 3 group, which is consistent with the presence of two diastereomers (both existing as two rotamers) due to partial epimerisation at the histidylidene α-carbon.
In addition, single crystals were obtained for the tripeptide 10 iridium complex 5. While the organometallic residue was clearly identified, the Ala-Ala residue was significantly disordered and did not allow refinement to converge. Nonetheless, this diffraction analysis supports the formation of the organometallic entity and the presence of a Ir-C NHC bond. 15 
Synthesis of histidylidene complexes containing a remote potentially coordinating amino acid residue
In order to promote chelation, amino acids containing a potentially coordinating functionality in the side chain were introduced on the histidylidene ligand. Methionine (Met) and 20 tyrosine (Tyr) were chosen to induce a C,S-and a C,O-bidentate binding mode of the histidylidene oligopeptide, respectively. 12 An alanine dipeptide linker was placed between the coordination sites in order to promote the formation of an α-helix. 21 Since a complete turn in a peptidic α-helix contains 3.6 amino acid 25 residues, the resulting tetrapeptides may adopt a conformation that is suitable for chelation where the side chain of the i+3 residue (i.e. Met/Tyr) is positioned almost eclipsed to the metalbound histidylidene unit. Because the side chains of tyrosine comprise a nucleophilic 30 phenol group, the imidazole ring of histidine was alkylated prior to the coupling with the oligopeptides. 11 The N δ ,N ε -dimethylated histidinium salt 8 was deprotected at the N-terminus using a solution of HCl in 1,4-dioxane, followed by an ion exchange to yield compound 9 in excellent yield (Scheme 3). The N-35 deprotected histidinium salt was subsequently coupled to the tripeptides Boc-Tyr-Ala-Ala-OH, which was synthesised in a manner similar to that described for Boc-Ala 3 -OH (cf. Scheme 1, route B). This coupling reaction afforded the tyrosine-containing histidinium tetrapeptide 10 as a highly hygroscopic solid. The 40 formation of the oligopeptide was confirmed by high-resolution mass spectrometry, which showed the expected signal for the cationic [M-Cl] fragment at 603.3135 amu (calculated 603.3142 amu). Furthermore the presence of four low field signals for the amide carbonyl functionalities and the ester in 13 C{ 1 H} NMR 45 spectroscopy supported successful coupling. In the 1 H NMR spectrum, the signal for the C ε -bound proton appeared at δ H 8.79 ppm for 10, which is at slightly higher field than in the deprotected monopeptide 9 (δ H 9.00 ppm). Similar to its Met homologue, 12 the histidinium tetrapeptide Analyses by NMR spectroscopy revealed the disappearance of the C ε H signal in the 1 H NMR spectra and the appearance of a low field doublet in the 13 C NMR spectra at δ C 182 ppm ( 1 J RhC = 51 Hz). Two sets of signals were observed, which were attributed to the presence of two rotamers. No epimerisation at C α was 60 observed when the metallation reaction was carried out at room temperature and for a short time only (1 h). 11b Comparison with model compounds by NMR spectroscopy indicated no spontaneous chelation of the tyrosine residue. While with the Met homologue 12, KPF 6 -mediated chloride abstraction 65 induced the formation of the macrocyclic chelate complex 13 (Scheme 4), no signs of phenol binding to the rhodium centre were observed by 1 H NMR spectroscopy when subjecting 11 to analogous conditions or after addition of AgPF 6 in the presence or absence of DIEA as proton scavenger. 70 The effect of potentially chelating amino acid residues in i+3 position was examined by CD spectroscopy in the far UV region for the rhodium tetrapeptides 6b, 12, and 13. The CD spectra of all the complexes in MeCN solution display a strong negative band at 198 nm and a small positive shoulder at 220 nm (Fig. 1) . 75 This typical random coil signature indicates an unordered secondary structure for all three complexes. 24 In MeCN, the solvent may potentially compete with methionine for rhodium coordination, which will result in ring-opening of the metallo- To prevent such ring-opening, analysis of the chelate tetrapeptide 13 were also performed in TFE as a noncoordinating and helix-inducing solvent. 25 This solvent change did not have any noticeable impact on the CD spectrum and the general features of an unordered peptide structure are still persistent. Introduction of a pronounced α-helical or β-turn motive therefore requires a longer oligopeptide scaffold. F NMR spectroscopy, the silyl ether 15 was formed as the major product along with small quantities of the enol ether 25 16 (Table 1) . 27 Monitoring the course of the reaction spectroscopically indicated a strong influence of the peptide scaffold on both the activity and the selectivity of the catalytically active rhodium centre. Complex 6a containing two alanine residues bound to the histidylidene ligand displayed identical 30 catalytic activity and selectivity towards 15 (within experimental error) as complex 6b comprising three Ala units (Table 2, Under identical conditions, the tyrosine-containing rhodium complex 11 showed catalytic activity and selectivity similar to complexes 6a,b containing only alanine residues, converting 79% of the ketone in 30 min with 93% selectivity towards 15 (entry 3). 55 The phenol group present in the side chain of the tyrosine residue seems to have no impact on the catalytic properties of the rhodium complex. In contrast, the methionine side chain in complex 12 is inhibiting catalytic turnovers (33% conversion after 30 min, entry 5) and decreases the selectivity from >90% to 60 around 70%. Apparently, the coordinating ability of the thioether side chain efficiently competes with substrate coordination to the catalytically active centre.
Attempts to enhance the catalytic activity of 11 by inducing in situ chelation were unsuccessful. For example, addition of 65 NEtiPr 2 (2 mol%) as a base for potentially scavenging HCl from complex 11 was unfavourable and gave only 57% conversion after 30 min. However, modification of the rhodium coordination sphere by abstracting the metal-bound chloride increased the catalytic activity of the rhodium complexes substantially. In the 70 N N Rh Cl presence of a tyrosine side chain, essentially complete conversion was achieved within 30 min upon activation of the catalyst precursor with AgOTf (entry 4, cf 97% conversion after 2 h with the RhCl unit). Interstingly, though, this enhanced catalytic activity is accompanied by a loss in selectivity from around 90% 5 towards formation of 15 to only 70%. In contrast, chloride abstraction from the methionine-containing oligopeptide rhodium complex 12 and generation of the macrocyclic rhodium cation 13 increased the selectivity (entry 6). Moreover, the activity is markedly higher than that of the AgOTf-activated complex 11 as 10 full conversion was accomplished within 10 min. This activity corresponds to an approximately four-fold increase of turnover rates, which is presumably not only induced by the cationic nature of the rhodium centre, but also by the beneficial effect of methionine coordination. Since tyrosine chelation was not 15 detected, similar effects due to intramolecular stabilisation of the metal centre are absent with complex 11. These results underline the relevance of chelation and indicate the unique behaviour of the methionine-containing catalyst. Further optimisation of the peptide scaffold may thus allow catalyst performance to be 20 further improved.
Conclusions
Based on appropriate histidine functionalisation, a synthetic methodology has been devised to form carbene complexes on an oligopeptide scaffold. Incorporation of an amino acid with a 25 donor site in the side chain in the i+3 position allows for the generation of a bidentate system, mimicking a metalloenzyme active site with two coordinated amino acids. Chelation has a beneficial effect on the catalytic activity of the metal centre. These principles may be extended to introduce functional sites 30 also at the C-terminus of the oligopeptide and to eventually engineer a second coordination site by biochemical methods through incorporation of appropriate amino acids that induce, for example, α-helical or β-turn conformations. Such an approach provides active site models in which the histidine is forced to 35 bind via C ε in a carbene binding mode, thus inducing new reactivity patterns. 10 For table of contents use only 15 Side-chain alkylated histidine was tethered to oligopeptides and metallated with iridium and rhodium to afford efficient peptidebased catalysts for the hydrosilylation of ketones.
